Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Where is Oral update ???

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Jan 26, 2021 11:38am

62 Views

Post# 32387529

RE:RE:Where is Oral update ???

That's my biggest fear here .....bad oral response !!!

Maxmoe wrote: Dude, that's not how warrants work. No more warrants have been, or will be , issued since the last financing. The deadline is for the using of warrants to buy more shares. The incentive, if there is one related to the warrants, would be to release all the good news they can to encourage investors to buy shares with their warrants (exercise of warrants). Or if you thrive on paranoia, maybe they are holding back bad news until all the warrants are exercised.

bligicka wrote: Are they holding news release so they can fill their pockets with cheap warrants ???